In a significant setback for British research, pharmaceutical titan Eli Lilly is closing its London research and development hub, putting over 100 jobs at risk and raising concerns about the UK's post-Brexit scientific competitiveness.
Exclusive: Diabetes and weight loss patients face financial strain as Eli Lilly's new Mounjaro KwikPens hit the market without the anticipated price reduction, maintaining a premium cost for the identical medication.
Danish pharmaceutical giant Novo Nordisk announces major restructuring, cutting 9,000 jobs globally. The move comes as competition intensifies in the lucrative weight-loss and diabetes drug market, challenging its blockbuster medications Ozempic and Wegov
Bravo's kingpin Andy Cohen stuns fans by admitting to micro-dosing weight loss drugs in a candid new interview, sparking a fiery debate on celebrity wellness trends.
Eli Lilly deals a major blow to UK Mounjaro users, announcing a smaller KwikPen, the removal of a key 12.5mg dose, and a staggering 170% price increase, sparking outrage and access fears.
Radio legend Howard Stern addresses swirling speculation about a rift with TV host Andy Cohen, setting the record straight in a candid on-air discussion that captivated listeners.
Exclusive: Desperate UK diabetics face a devastating health crisis as they are cut off from the 'miracle' weight-loss drug Mounjaro (tirzepatide) due to soaring costs and an NHS postcode lottery, with patients fearing for their lives.
A groundbreaking new weight loss pill from Eli Lilly, orforglipron, has demonstrated remarkable results in a UK trial, offering a potential oral alternative to injectable treatments like Mounjaro for combating obesity.
A new oral weight loss medication, Orforglipron, shows transformative potential in UK clinical trials, matching the efficacy of injectable treatments like Mounjaro and offering new hope for tackling obesity.
Explosive court filings allege Donald Trump violated a gag order by attacking key witnesses, including Stormy Daniels, in his New York criminal trial. The judge is now considering contempt charges.
Disney+ has pulled the plug on the highly anticipated 'Chad Powers' series, starring Glen Powell, in a major strategic U-turn that has stunned the industry and left fans reeling.
A bombshell theory has set the internet ablaze, suggesting 'Euphoria' star Sydney Sweeney is secretly dating music mogul Scooter Braun, the longtime rival of global superstar Taylor Swift. Dive into the viral speculation that has fans and critics alike ut
Virgin Radio DJ Chris Evans offers a heartfelt update on his 13-year-old son Eli's recovery from a major operation, sharing a rare and touching family photo from the hospital.
In a dramatic move, the Trump administration has dismissed CDC Director Dr. Mandy Cohen and named controversial figure Jim O'Neill as her replacement, signalling a major shift in US public health policy.
Eli Lilly drastically cuts the price of its Mounjaro injection in the UK, making the revolutionary diabetes and weight loss treatment more accessible. The move follows a landmark NHS supply deal.
The MHRA has officially approved the weight-loss injection Mounjaro (tirzepatide) for the UK market, with a set price, marking a significant new option in the nation's battle against obesity.
Exclusive: A perfect storm of NHS price hikes and soaring demand for the 'miracle' drug tirzepatide triggers a national shortage, leaving thousands of diabetics and weight-loss patients in limbo. Fears grow as stockpiling begins.
The weight loss drug Mounjaro (tirzepatide) is launching in the UK, challenging Ozempic. Experts warn of potential shortages and urge prescriptions for those with clinical need, not casual use.
The UK's medicines watchdog approves the weight loss injection Mounjaro (tirzepatide), offering a powerful new option in the fight against obesity. Discover its price, how it works, and where to get it.
Eli Lilly suspends shipments of obesity drug Mounjaro to the UK, triggering a major price surge and leaving thousands of patients in limbo amid supply chain restructuring.
Exclusive: In a dramatic blow to the Trump administration, two senior CDC directors have quit, citing 'profound ethical violations' and political interference in scientific work during a new public health crisis.
A groundbreaking oral weight loss drug, Orforglipron, has demonstrated dramatic results in a recent clinical trial, offering a potential pill-based alternative to popular injectable treatments like Wegovy. The study shows significant weight reduction, spa
Singer-songwriter Martha Wainwright curates a deeply personal 'Honest Playlist' for The Guardian, sharing the profound tracks that shaped her life and career, from Leonard Cohen's poetry to Tracy Chapman's truth.
Breakthrough UK study reveals Retatrutide, the new triple-action 'Godzilla' weight loss injection, is dramatically more effective than its predecessors, helping patients lose up to 24% of their body weight in just 48 weeks.
UK health officials issue a critical safety alert for the type 2 diabetes drug Mounjaro (tirzepatide), linking it to severe stomach paralysis and intestinal blockages. Patients are urged to recognise the warning signs.
Exclusive details reveal the Hollywood couple's lavish spending spree and property hunt in Australia just months before announcing their divorce after 14 years of marriage.
An in-depth exploration of the disturbing phenomenon where fervent admiration for celebrities curdles into dangerous fixation, harassment, and hate. Nick Cohen's chilling analysis reveals the psychological underpinnings of this modern malaise.
Real Housewives of New York star Racquel Chevremont makes shocking claims about her abrupt exit, alleging producers deemed her lifestyle 'not messy enough' for reality TV drama.
The cost of diabetes and weight-loss drugs Mounjaro and Ozempic has surged, sparking concerns over affordability and market competition. Experts weigh in on the implications.
Pharmaceutical giant Eli Lilly announces a significant price increase for its diabetes and weight-loss drug Mounjaro in the UK, sparking concerns over affordability and access.